Guardian Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$609K Sell
7,141
-19
-0.3% -$1.72K 0.05% 144
2026
Q2
$656K Sell
7,160
-301
-4% -$26.3K 0.06% 139
2026
Q1
$637K Sell
7,461
-54
-0.7% -$4.81K 0.05% 136
2025
Q4
$708K Buy
7,515
+4,105
+120% +$322K 0.06% 144
2025
Q3
$269K Hold
3,410
– – 0.02% 160
2025
Q2
$312K Sell
3,410
-35
-1% -$3.2K 0.03% 157
2025
Q1
$323K Sell
3,445
-50
-1% -$4.48K 0.03% 144
2024
Q4
$306K Buy
+3,495
New +$334K 0.03% 144

Other funds holding CL

Guardian Partners's CL Position: Q3 2026 in Review

Guardian Partners reduced its Colgate-Palmolive (CL) stake by 0.27% in Q3 2026, selling an estimated $1.72K and leaving 7,141 shares worth $609K. The position accounts for 0.05% of the portfolio, ranked #144.

Guardian Partners first reported a position in CL in Q4 2024 and has held it in 8 quarters since. The position peaked at $708K in Q4 2025. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Guardian Partners held 7,141 shares of Colgate-Palmolive worth $609K as of Q3 2026.
  • Guardian Partners sold 19 Colgate-Palmolive shares in Q3 2026, an estimated $1.72K.
  • Colgate-Palmolive made up 0.05% of Guardian Partners's portfolio in Q3 2026, its #144 holding.
  • Guardian Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
  • Guardian Partners's Colgate-Palmolive position peaked at $708K in Q4 2025.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.